InvestorsHub Logo
Followers 39
Posts 2870
Boards Moderated 0
Alias Born 12/06/2003

Re: infunf post# 699

Thursday, 10/19/2017 9:49:18 AM

Thursday, October 19, 2017 9:49:18 AM

Post# of 824
Are people supposed to be hoping revenue will be on the 10q...or is that not yet?

Morning, Infunf.

"Not yet" definitely, I would say.

SVON's preclinical and legacy technology is about to be swallowed up by Eloxx which is contemplated at 70% of assets after a kind of reverse merger before additional funding presumably attracted primarily, if not exclusively, by Eloxx's research on rare nonsense diseases, headlined by cystic fibrosis and muscular dystrophy.

http://tinyurl.com/KindleWireless

The odd nomenclature of "nonsense diseases" derives from antisense technology denoting a class of inherited genetic defects that essentially come from defective or missing DNA:

http://tinyurl.com/y77hnrty

That may or may not be helpful to you but I am sure you and others must realize that the erstwhile popularly-misnamed anti-GMO technology I originally bought years ago has left little but ashes after destruction by the delusional vampire hunters. That battle is long over here and maybe the Sevion technology will fare no better but Eloxx may have a huge winner eventually with emphasis on MAY and EVENTUALLY.

JMO.

Best, Terry
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELOX News